Volume 1 · Issue 5
Neurodegeneration & the Aging Brain
From cognitive reserve to longitudinal biomarkers, this issue examines the progression of neurodegenerative conditions and the evidence used to distinguish aging from disease.
100 Creative Commons readings · Paulina Valenzuela, MD, Editor-in-Chief
Issue 5 · Reading list
Explore the research
100 readings · Page 2 of 5
- Original article
Parkinson’s disease and related disorders · CC BY 4.0
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
GBD 2016 Parkinson's Disease Collaborators
The Lancet. Neurology · 2018
- Original article
Parkinson’s disease and related disorders · CC BY 4.0
The SH-SY5Y cell line in Parkinson's disease research: a systematic review.
Helena Xicoy, Helena Xicoy, Bé Wieringa, Gerard J M Martens
Molecular neurodegeneration · 2017
- Original article
Parkinson’s disease and related disorders · CC BY 4.0
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy.
Gregor K Wenning, Iva Stankovic, Luca Vignatelli, Alessandra Fanciulli et al.
Movement disorders : official journal of the Movement Disorder Society · 2022
- Original article
Parkinson’s disease and related disorders · CC BY 4.0
Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases.
Martin Steger, Francesca Tonelli, Genta Ito, Paul Davies et al.
eLife · 2016
- Original article
Parkinson’s disease and related disorders · CC BY 4.0
Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review.
Klaus Seppi, K Ray Chaudhuri, Miguel Coelho, Susan H Fox et al.
Movement disorders : official journal of the Movement Disorder Society · 2019
- Original article
Parkinson’s disease and related disorders · CC BY 4.0
Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction.
Paolo Calabresi, Alessandro Mechelli, Giuseppina Natale, Laura Volpicelli-Daley et al.
Cell death & disease · 2023
- Original article
Parkinson’s disease and related disorders · CC BY 4.0
Neuroinflammation in Parkinson's disease and its potential as therapeutic target.
Qinqin Wang, Yingjun Liu, Jiawei Zhou
Translational neurodegeneration · 2015
- Original article
Parkinson’s disease and related disorders · CC BY 4.0
Prevalence of Parkinson's disease across North America.
C Marras, J C Beck, J H Bower, E Roberts et al.
NPJ Parkinson's disease · 2018
- Original article
Parkinson’s disease and related disorders · CC BY 3.0
Ageing and Parkinson's disease: why is advancing age the biggest risk factor?
Amy Reeve, Eve Simcox, Doug Turnbull
Ageing research reviews · 2014
- Original article
Parkinson’s disease and related disorders · CC BY 4.0
Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation.
Stefano Romano, George M Savva, Janis R Bedarf, Ian G Charles et al.
NPJ Parkinson's disease · 2021
- Original article
Parkinson’s disease and related disorders · CC BY 4.0
Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson's disease treatment.
Ryosuke Kojima, Daniel Bojar, Giorgio Rizzi, Ghislaine Charpin-El Hamri et al.
Nature communications · 2018
- Original article
Parkinson’s disease and related disorders · CC BY 4.0
Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson's disease.
Tushar Kamath, Abdulraouf Abdulraouf, S J Burris, Jonah Langlieb et al.
Nature neuroscience · 2022
- Original article
Parkinson’s disease and related disorders · CC BY 4.0
Oxidative stress and Parkinson's disease.
Javier Blesa, Ines Trigo-Damas, Anna Quiroga-Varela, Vernice R Jackson-Lewis
Frontiers in neuroanatomy · 2015
- Original article
Parkinson’s disease and related disorders · CC BY 4.0
Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications.
Marta Pajares, Ana I Rojo, Gina Manda, Lisardo Boscá et al.
Cells · 2020
- Original article
Parkinson’s disease and related disorders · CC BY 4.0
Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
Zhe Zhao, Jingwen Ning, Xiu-Qi Bao, Meiyu Shang et al.
Microbiome · 2021
- Original article
Parkinson’s disease and related disorders · CC BY 4.0
Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease.
Benjamin G Trist, Dominic J Hare, Kay L Double
Aging cell · 2019
- Original article
Parkinson’s disease and related disorders · CC BY 4.0
Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.
J R Bedarf, F Hildebrand, L P Coelho, S Sunagawa et al.
Genome medicine · 2017
- Original article
Parkinson’s disease and related disorders · CC BY 4.0
The Role of Astrocyte Dysfunction in Parkinson's Disease Pathogenesis.
Heather D E Booth, Warren D Hirst, Richard Wade-Martins
Trends in neurosciences · 2017
- Original article
Parkinson’s disease and related disorders · CC BY 2.5
Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
YaXing Gui, Hai Liu, LiShan Zhang, Wen Lv et al.
Oncotarget · 2015
- Original article
Parkinson’s disease and related disorders · CC BY 4.0
Current and projected future economic burden of Parkinson's disease in the U.S.
Wenya Yang, Jamie L Hamilton, Catherine Kopil, James C Beck et al.
NPJ Parkinson's disease · 2020
